AI ‘promising’ for use in geriatrics, but ethical concerns remain, researchers say
By
Aaron Dorman
Sep 22, 2023
A new meta-study on using AI within geriatrics praises AI as a “valuable asset” but still warns about the need for future research and potential ethical concerns.
Allopurinol may cut risk for neurodegenerative diseases
May 19, 2023
Allopurinol linked to 13 to 34 percent lower risk for Parkinson disease, Alzheimer disease, ALS
Social isolation may be independent risk factor for dementia
Jun 10, 2022
Lower gray matter volumes in temporal, frontal, other regions were seen in socially isolated individuals.
Silverado first US organization to receive Alzheimer’s Disease International accreditation
By
Kathleen Steele Gaivin
Apr 24, 2024
Irvine, CA-based Silverado has become the first US-based organization to earn accreditation from Alzheimer’s Disease International after becoming the first care provider anywhere to receive the accreditation...
Levetiracetam well-tolerated for Alzheimer’s disease
Oct 01, 2021
It does not improve primary outcome but did improve performance on certain cognitive tasks in those with epileptiform activity.
High BP visit-to-visit variability linked to dementia risk in late life
Oct 31, 2023
Higher blood pressure variability was not associated with higher lifetime dementia risk at age 60, 70 or 80 years.
Lower cutoff points for Montreal cognitive assessment needed
Jan 17, 2024
A high false-positive rate was seen when used in primary care with a diverse patient population.
Blood tests and phone apps: The future of diagnosing Alzheimer’s?
By
Lois A. Bowers
Apr 08, 2019
Last week in a blog post, Bill Gates shared some exciting ways that Alzheimer’s disease might be diagnosed in the future.
Dementia incidence varies by race, ethnicity
Apr 21, 2022
Among U.S. veterans, the rates of dementia were highest for Blacks and Hispanics.
Sleep-disordered breathing linked to medial temporal lobe atrophy in seniors
Jun 02, 2023
Higher sleep apnea severity was related to lower medial temporal lobe subregion volumes in amyloid-positive, but not amyloid-negative, individuals.